Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Dr. Reddy's makes and sells affordable generic medicines and active drug ingredients worldwide.
Dr. Reddy's Laboratories is a big Indian drugmaker that mostly sells copycat versions of medicines whose original patents have expired. These are called generics, and they cost far less than the brand-name originals. The company's main customers are hospitals, pharmacies, and governments in the United States, India, Russia, and other countries. It makes money by selling huge volumes of these low-priced pills, plus the raw chemical ingredients that go into them.
Think of it as the store-brand version of the medicine aisle. The active ingredient works the same, but you pay a fraction of the price. The United States is its biggest market, where it sells everything from cancer drugs to stomach medicines. In India, its home country, it sells directly to patients under familiar brand names. It also has a growing business making complex injectable drugs and biosimilars, which are cheaper copies of biologic medicines made from living cells. These are harder to copy, so the profits are better.
The company was founded in 1984 by a scientist named Kallam Anji Reddy, who wanted to make quality medicines affordable for everyone. Today it spends heavily on research to crack complicated drugs and buys smaller companies to expand its product lineup. It pays a dividend and reinvests much of its cash into new factories and regulatory approvals, which are the keys to selling in rich countries. Recent focus areas include oncology, or cancer treatment, and the fast-growing market for cheaper versions of expensive biologic drugs. For a curious reader, the story is simple: it is a volume business built on making medicine cheaper for millions of people.
Saved answer · last researched 11 Oct 2026